Introduction {#Sec1}
============

Hemorrhagic enteritis (HE) is an economically important disease of turkeys characterized by depression, splenic enlargement, intestinal haemorrhages and sudden death \[[@CR1]\]. The disease is caused by turkey adenovirus 3 (TAdV-3), also known as hemorrhagic enteritis virus (HEV), a member of genus *Siadenovirus A* \[[@CR2]\]. Oral infection of susceptible turkeys with pathogenic TAdV-3 strains results in well-characterized splenomegaly and intestinal bleeding in 4 to 6 days causing subclinical infections and mortality \[[@CR3]\]. Although TAdV-3 remains one of the most important causes of economic loss to turkey industry, critical molecular determinants of virulence and factors affecting virus replication are not well understood. This may be in part because of unavailability of an efficient "in vitro" tissue culture system for propagation of TAdV-3 \[[@CR4]-[@CR6]\].

The genome of TAdV-3 is 26,263 bp \[[@CR7]\]. Although, TAdV-3 genomic organization of central block of genus-common genes \[[@CR8]\] appears similar to that of other adenovirus genomes \[[@CR7]\], the left (E1) and right (E4) terminal regions appear absent. Interestingly, TAdV-3 encodes a genus specific protein, which shows similarity to bacterial sialidase protein \[[@CR8]\]. Although Western blot analysis of purified TAdV-3 particles isolated from crude spleen extract revealed presence of eleven structural polypeptides with apparent molecular weight ranging from 9.5 to 96 kDa \[[@CR9]\], no systematic study has been performed to identify the precise protein composition of purified TAdV-3 particles.

In recent years, mass spectrometry (MS) based proteomic characterization has revealed important insights into viral replication, tropism and virulence for a number of different enveloped viruses \[[@CR10]-[@CR14]\]. In contrast, a few proteomic studies have been reported for non-enveloped viruses \[[@CR15]-[@CR18]\]. Additionally, there is now compelling evidence suggesting that host cellular proteins incorporated in the virions play an important role in viral replication and pathogenesis \[[@CR10],[@CR13],[@CR19],[@CR20]\]. Using MS based approaches, a number of host proteins have been reported to be incorporated into RNA viruses ("human immunodeficiency virus-1 \[[@CR10],[@CR13]\]"; "simian immunodeficiency virus \[[@CR21]\]"; "respiratory syncytial virus \[[@CR22]\]; hepatitis C virus \[[@CR23]\]"; "swine hepatitis E virus \[[@CR24]\]"; "coronavirus \[[@CR25]\]" and "influenza \[[@CR20],[@CR26]\]") or DNA viruses ("herpes simplex virus 1 \[[@CR27]\]"; "African swine fever virus \[[@CR28]\]"; "KSHV \[[@CR29]\]"; "Marek's disease virus (MDV) \[[@CR30]\]", and "mimivirus \[[@CR31]\]"). However, to the best of our knowledge, characterization of the host cellular factors integrated into virions for any member of *Adenoviridae* family including TAdV-3 has not been reported so far.

Here, we report the protein composition of the purified TAdV-3 particles by performing a comprehensive proteomic analysis utilizing liquid chromatography-mass spectrometry (LC-MS/ MS). Our analysis resulted in successful identification of 13 viral structural proteins and 18 host-incorporated proteins. Moreover, incorporation of two host proteins in purified virions was verified by Western blot analysis using available immunological reagents.

Materials and methods {#Sec2}
=====================

Turkey and viruses {#Sec3}
------------------

All turkey procedures were approved by University Committee of Animal Care and Supply (protocol \# 19940211) at the University of Saskatchewan, Saskatoon, Canada according to guidelines set by the Canadian Council of Animal Care.

Day-old Hybrid poults obtained from Chinook belt Hatcheries, Calgary, Canada were housed in isolation rooms throughout the experiments. The avirulent TAdV-3 isolate (pheasant origin) was passaged in sero negative turkeys by oral inoculation and purified from crude spleen extracts, as described earlier \[[@CR32]\].

Virion purification {#Sec4}
-------------------

The TAdV-3 virions were purified as previously described \[[@CR9]\]. The proteinase K (pK) treatment of purified TAdV-3 virions was performed as described previously \[[@CR33]\]. Briefly, double CsCl-purified virions were incubated in 1 mL of MNT buffer (30 mM morpholineethanesulfonic acid \[MES\], 10 mM NaCl, and 20 mM Tris--HCl \[pH 7.4\]) containing proteinase K \[0 to 20 μg\] (Roche, Mannheim, Germany) for 45 min at room temperature and subsequently treated with "2 mM phenylmethyl-sulfonyl fluoride" (Roche) prior to purification by CsCl density gradient centrifugation. Purified virions were resuspended in 10% glycerol and stored at −80 °C until further use. The experiments were performed in triplicate employing three independent virus preparations.

Negative staining and transmission electron microscopy {#Sec5}
------------------------------------------------------

Electron microscopy was performed on CsCl~2~ gradient purified TAdV-3 virions (proteinase K treated or untreated) at EM facility at Biology department, University of Victoria, BC, Canada, as described \[[@CR34]\]. Briefly, for negatively stained preparation, CsCl~2~ gradient purified virus was first applied onto carbon and formvar coated grids, washed with H~2~0 and stained with 2% aqueous phosphotungstic acid. The specimens were photographed using a charge-coupled device camera (Advanced Microscopy Techniques, AMT CCD camera equipped Hitachi H7000 TEM operating at 75 kv).

Antibodies {#Sec6}
----------

Production and characterization of anti-TAdV-3 serum and monoclonal antibodies (MAbs) recognizing TAdV-3 hexon (15G4) and fiber (87--03) proteins has been described earlier \[[@CR4],[@CR9]\]. Chicken polyclonal anti-human hemoglobin serum (ab28961) was purchased from Abcam (Cambridge, MA, USA). Rabbit polyclonal anti-human collagen type VI alpha-1 serum (COL6A1) was purchased from antibodies-online Inc. (Atlanta, GA, USA). Alkaline phosphatase conjugated goat anti-rabbit (Sigma Aldrich) and peroxidase-conjugated goat "anti-turkey" IgG (KPL, Maryland, USA) were used as described \[[@CR4],[@CR9]\].

Western blotting {#Sec7}
----------------

Proteins from purified TAdV-3 were separated by sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (PAGE) on 10--15% or 4--15% precast gradient gels (Bio-Rad),transferred to nitrocellulose membrane and probed with protein specific antibodies as described previously \[[@CR9]\].

In solution trypsin digestion {#Sec8}
-----------------------------

Proteins from CsCl~2~ gradient purified virion-enriched (proteinase K treated or untreated) samples were diluted with 200 mM ammonium bicarbonate prior to reduction with 200 mM dithiothreitol and incubated 30 min at 37 °C. Cysteine sulfhydryl groups were alkylated with 20 μL of 100 mM iodoacetamide (30 min at 37 °C in darkness). Each sample was digested with 5 μg of trypsin (Promega) at 37 °C for 16 h \[[@CR33],[@CR35]\]. Finally, the samples were de-salted on a Waters HLB Oasis column, speed vac concentrated and stored at −80 °C prior to LC-MS analysis.

### LC-MS/MS analysis {#Sec9}

The peptide mixtures were separated by on-line reverse phase chromatography using a EASY-nLC II system (Thermo Scientific) with a reversed-phase Magic C-18AQ pre-column (100 μm I.D., 2 cm length, 5 μm, 100 Å, Michrom Bio Resources Inc, Auburn, CA, USA) and reversed phase nano-analytical column Magic C-18AQ (75 μm I.D., 15 cm length, 5 μm, 100 Å, Michrom Bio Resources Inc, Auburn, CA, USA) at a flow rate of 300 1/min. The resulting peptides were analyzed by the chromatography system, which was coupled on-line with a LTQ OrbitrapVelos mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) equipped with a NanosprayFlex source (Thermo Fisher Scientific) as described previously \[[@CR33],[@CR35]\]. The data was acquired with keratin and trypsin peptide mass exclusion lists.

MS/MS data analysis {#Sec10}
-------------------

Raw files were analysed with Proteome Discoverer 1.4 software suite (Thermo Scientific). Parameters for the spectrum selection to generate peak lists of the collision-induced "dissociation (CID) spectra were activation type: CID"; (s/n cut-off: 1.5; total intensity threshold: 0; minimum peak count: 1; precursor mass: 350--5000 Da). The peak lists were submitted to an in-house Mascot 2.3 server against "the following databases": Uniprot_Trembl 20111103 (17 651 715 sequences; 5,747,683, 275 residues) and Uniprot-Swissprot 20110104 (523 151 sequences; 184 678 199 residues) all species taxonomy.

Database search parameters were as follows: precursor tolerance 8 ppm; MS/MS tolerance 0.6 Da; Trypsin enzyme 1 missed cleavages; Fourier Transform Ion Cyclotron Resonance (FT-ICR) instrument type; fixed modification: carbamidomethylation (C); variable modifications: deamidation (N,Q); oxidation (M). The Decoy database Percolator settings: Max delta Cn 0.05; Target FDR strict 0.01, Target FDR relaxed 0.05 with validation based on q-Value. Additional virus only species searches were also performed with tolerances previously mentioned. All data were also searched against NCBI (*Gallus gallus* (chicken)) database to detect viral and host proteins. Only sequences identified with a mascot score value greater than 30 were considered as significant. Protein identifications were accepted when the peptide probability was greater than 95.0% \[[@CR33],[@CR35]\], the protein probability greater than 99.0%, and contained at least 2 identified peptides. Peptide identifications were systemically evaluated manually.

Results {#Sec11}
=======

Purification of TAdV-3 virions {#Sec12}
------------------------------

Due to difficulty in propagating turkey adenovirus 3 in cell culture system, TAdV-3 was propagated in six to 8 week old turkeys. TAdV-3 virions were purified from spleens of turkeys inoculated orally with an avirulent vaccine strain of TAdV-3 \[[@CR4],[@CR9]\] (Figure [1](#Fig1){ref-type="fig"}A). Following CsCl~2~ density gradient purification, two distinct bands were observed, the upper band (present at lower density) containing capsid and the lower band (at higher density, between 1.25 and 1.35) containing complete infectious viruses (Figure [1](#Fig1){ref-type="fig"}B, left panel). The lower band was subjected to second round of CsCl~2~ density gradient purification resulting in single band containing purified virions (Figure [1](#Fig1){ref-type="fig"}B, right panel). Virion-enriched preparations were checked for quality by negative stain transmission electron microscopy (TEM) (Figures [1](#Fig1){ref-type="fig"}C and D). As seen, virions demonstrated uniform, intact TAdV-3 virus particles of 100 nm diameter. These TEM results were consistent with the quality and apparent purity reported earlier \[[@CR33],[@CR35]\]. The purity of the virion preparation was also determined by Western blot analysis using turkey anti-TAdV-3 sera. As seen in Figure [1](#Fig1){ref-type="fig"}E, polypeptides of 96 K (hexon), 57 K (IIIa), 52 K (penton base), 29 K (fiber) and 24 K (pVI) were detected in CsCl~2~ purified TAdV-3 virions. These findings suggest that our enrichment procedure yielded a highly purified preparation of TAdV-3 virions.Figure 1**Purification of TAdV-3 virions.** **A** *Strategy for enrichment and purification of TAdV-3 virions*. Flow diagram depicts the strategy. **B** CsCl2 purification of TAdV-3. The lower band containing mature viruses (left panel) subjected to second round of CsCl (right panel). **C**--**E** *Analysis of TAdV-3 virions purity.* Electron micrograph of CsCl purified TAdV-3 negatively stained with 2% aqueous phosphotungstic acid (Direct magnification 100000X) (**C**) and (direct magnification 150000X) (**D**). **E** *Analysis of TAdV-3 polypeptides*. Purified TAdV-3 proteins were separated by 10--15% SDS-PAGE and analyzed by Western blot using turkey anti-TAdV-3 serum \[[@CR4],[@CR9]\] and peroxidase-linked goat anti-turkey IgG antibodies (right panel). The identified polypeptides (lane 1) are depicted. Molecular weight markers (MW) in kDa are shown on the left of the panel.

Protein composition of CsCl~2~ purified TAdV-3 virions {#Sec13}
------------------------------------------------------

The protein composition of TAdV-3 virions was analyzed by the method of in-solution trypsin "digestion a gel-free approach" to MS that subject the entire sample to sequential one-dimensional reversed-phase chromatography coupled on-line to MS/MS analysis (1D-nanospray-LC-MS/MS). This method eliminates the problems reported with proteins that either enter gel poorly or extracted inefficiently from the gel slices. Our LC-MS/MS analysis revealed a total of 15 virus-encoded proteins packaged in the purified TAdV-3 virions. This included 13 proteins, which have been detected in human adenovirus 5 (HAdV-5) virions \[[@CR16]\] (Table [1](#Tab1){ref-type="table"}), a novel uncharacterized hypothetical viral protein designated as TaV3gp04 (Table [1](#Tab1){ref-type="table"}, Additional file [1](#MOESM1){ref-type="media"}) and a non-structural viral protein (22 K) to be associated with TAdV-3 virions. In addition to TAdV-3 encoded viral proteins, interestingly 26 cellular proteins appeared to be associated with purified TAdV-3 virions (Table [2](#Tab2){ref-type="table"}).Table 1TAdV-3 proteins identified by LC-MS/MS**LC-MS/MSProtein nameMW (kDa)** ^a^**No. of peptidesMascot score** ^**b**^**Sequence coverage (%)** ^**c**^pVI24.98146437869pIIIA57.5259237796pVII13.20163198491IVa242.3639104648Penton Base34.174685754Hexon101.654265923pVIII21.753565581Fiber29.131862029**Hypothetical Protein (TaV3gp04)13.321745235**DBP44.211338912Sialidase64.991626pX6.15913729Adenain25.33911318pTP70.727102922 K10.5154229A novel virion-associated viral protein is shown in bold black.^a^Theoritical molecular mass.^b^A Mascot score ≥35 is significant (*p* \< 0.05).^c^Sequence coverage is based on peptides with an unique sequence.Table 2Cellular proteins associated with purified TAdV-3 virions identified by LC-MS/MS**LC-MS/MSProtein nameMW (kDa)** ^a^**No. of peptidesMascot score** ^b^**Sequence coverage (%)** ^c^Actin42.365660738TAR DNA binding protein 4344.902265624Tublin beta550.282553521Tubulin alpha-1A50.781944426LUC7 like147.602848228Tublin beta350.092533820High mobility group protein B123.081334934High mobility group protein B223.98242272478 kDa glucose-regulated protein72.08211355Myeloid protein 136.411424023Desmin53.301621211Cathelicidin-316.61514632Protein PML35.991315818Vimentin53.161615717Splicing factor U2AF28.19715420Collagen alpha-1 (VI) chain110.0514632Elongation factor 1-alpha49.48614315Protein syndesmos33.4441403Ferritin17.13812922Serine/arginine-rich splicing factor 5a27.152767Fibronectin276.0173762Gallinacin-27.4927512Cathespsin B38.473709Hemoglobinsubunit beta16.6266419L-amino acid oxidase59.083563Hemoglobin subunit alpha-A15.1034217^a^Theoritical molecular mass.^b^A Mascot score ≥35 is significant (*p* \< 0.05).^c^Sequence coverage is based on peptides with an unique sequence.

Protein composition of proteinase K treated CsCl purified TAdV-3 virions {#Sec14}
------------------------------------------------------------------------

To determine if the host proteins are actually incorporated into the virions, the purified TAdV-3 virions were treated with proteinase K (20 μg/mL) and subjected to another round (third round) of CsCl~2~ purification. The proteinase K treated and untreated, purified virions were then analysed by Western blotting. Proteinase K treatment degrades fiber protein protruding from the capsid but does not degrade hexon protein not protruding from the capsid. As seen in Figure [2](#Fig2){ref-type="fig"}A, hexon protein could be detected in proteinase K treated or untreated TAdV-3 virions. In contrast, fiber protein could only be detected in untreated virions, but not in proteinase K treated virions. Moreover, TEM analysis suggested that the virions were intact and maintained virion integrity after proteinase K treatment and CsCl~2~ density gradient purification (Figure [2](#Fig2){ref-type="fig"}B).Figure 2**Proteinase K digestion of purified TAdV-3 virions.** **A** Proteins from purified TAdV-3 untreated (lane 1) or treated (lanes 2--5) with indicated amounts of proteinase K were separated by 10--15% SDS-PAGE, transferred to nitrocellulose and probed by Western blot using anti-TAdV-3 serum. The hexon protein and the fiber protein are depicted by an arrow. Concentration of proteinase K in μg is indicated on top of the panels. **B** Purified TAdV-3 treated with 20 μg of proteinase K were negatively stained with 2% aqueous phosphotungstic acid and analyzed by transmission electron microscopy. (Direct magnification 50000×, left panel) and (direct magnification 150000×, right panel).

The LC-MS/MS analysis of proteinase K treated CsCl~2~ density gradient purified TAdV-3 virions identified eleven virus-encoded proteins (hexon, pVI, pVII, penton base, pVIII, sialidase, IIIA, adenain, pX, IVa2 and DBP) previously reported to be in other adenoviruses (Table [3](#Tab3){ref-type="table"} and Figure [3](#Fig3){ref-type="fig"}A) \[[@CR16]\]. In addition, a novel viral protein TaV3gp04 remains an integrated part of proteinase K treated TAdV-3 virions (Table [3](#Tab3){ref-type="table"}, Additional file [1](#MOESM1){ref-type="media"}). As expected, peptides representing fiber protein were not detected in proteinase K treated TAdV-3 virions. In addition, pTP and 22 K virion proteins were not detected in proteinase K treated TAdV-3 (Table [3](#Tab3){ref-type="table"}). The high mascot scores and number of peptides observed for hexon, pVI and pVII presumably reflect the fact that they are perhaps the most abundant proteins in the TAdV-3 particles.Table 3TAdV-3 proteins identified by LC-MS/MS after proteinase K treatment**LC-MS/MSProtein nameMW (kDa)** ^a^**pK** ^**b**^**No. of peptidesMascot score** ^**c**^**Sequence coverage (%)** ^**d**^Hexon101.653+71132737PVI24.989+1556032PVII13.201+2446770**Hypothetical Protein(TaV3gp04)13.32+1016536**Fiber\-\-\-\--Penton Base34.179+1315319PVIII21.75+813512Sialidase64.9+28410IIIA57.52+108310Adenain25.33+2556PX6.15+13913IVa242.36+2352DBP44.21+1242pTP\-\-\-\--22 K\-\-\-\--A novel virion-associated viral protein is shown in bold black.^a^Theoritical molecular mass.^b^pK, proteinase K treatment +.^c^A Mascot score ≥35 is significant (*p* \< 0.05).^d^Sequence coverage is based on peptides with an unique sequence.Figure 3**Identification of viral and host virion proteins.** Venn diagrams of viral (**A**) and host proteins (**B**) detected in TAdV-3 untreated and proteinase K-treated samples by in-solution tryptic digestion followed by analysis using 1D-liquid chromatography combined with a mass spectrometer (LC-MS/MS). **C** Eighteen host-incorporated proteins identified in purified proteinase treated TAdV-3 virions in the presence of proteolytic digestion are classified based on their known functions.

Interestingly only 18 host proteins were exclusively detected in proteinase K treated TAdV-3 virions (Table [4](#Tab4){ref-type="table"} and Figure [3](#Fig3){ref-type="fig"}B). Notably, thirteen of these host proteins were the same as detected in the untreated TAdV-3 virions (Table [4](#Tab4){ref-type="table"}, Figure [3](#Fig3){ref-type="fig"}B) indicating that these proteins are part of the TAdV-3 virions. Among these proteins, promyelocytic leukemia protein (PML) isoform X6 (Additional file [2](#MOESM2){ref-type="media"}), collagen alpha-1(VI) chain (Additional file [3](#MOESM3){ref-type="media"}), haemoglobin subunit alpha (Additional file [4](#MOESM4){ref-type="media"}) and haemoglobin subunit beta (Additional file [5](#MOESM5){ref-type="media"}) appeared abundant. The PML protein appears as abundant as viral structural protein pVIII or penton base peptide. In addition, five host proteins namely, vitronectin, collagen alpha-3 (VI) chain, collagen alpha-2 (VI) chain, tyrosine protein phosphatase and turkey heterophil peptide 2 (THP-2) were only detected in proteinase K treated TAdV-3 virions.Table 4Cellular proteins associated with purified TAdV-3 virions after proteinase K treatment**LC-MS/MSProtein nameMass (kDa)** ^a^**No. of peptidesMascot score** ^b^**Sequence coverage (%)** ^**c**^**Protein functionReported in other virusesProtein PML isoform X648.4814110Innate immunity**-**Collagen alpha-1 (VI) chain110171017Cell adhesion**-Vitronectin52.241005Cell adhesionSIV^21^, KSHV^29^**Hemoglobin subunit alpha --A like15.559924Innate immunityCorona** ^**26**^ **, Influenza** ^**20**^Collagen alpha-3 (VI) chain34099210Cell adhesion-Collagen alpha-2 (VI) chain1105915Cell adhesionInfluenza^20^**Ferritin17.149020Virus replicationHCV** ^**24**^ **, sHEV** ^**25**^**Elongation factor 1-alpha47.62693Virus replicationHIV** ^**13**^**Hemoglobin subunit-beta like16.386627Innate immunityCSFV** ^**45**^Tyrosine protein phosphatase682632Cell division-Antimicrobial peptide THP-27.676448Innate immunity-**Splicing factor U2AF28.75609Splicing factorKSHV** ^**29**^**Serine/arginine splicing factor 5α30.11433Splicing factorInfluenza** ^**20**^**TAR DNA binding protein 4345.03402TranscriptionHSV** ^**14**^ **,RSV** ^**23**^**L-amino acid oxidase59.084407Flavoprotein-Gallinacin-27.643926Innate immunity-Tubulin alpha-1A50.94324CytoskeletonHIV** ^**13**^ **, Influenza** ^**11**^ **, ASFV** ^**28**^**Actin42.23325CytoskeletonHIV** ^**13**^ **, Influenza** ^**11**^ **, ASFV** ^**28**^Protein subsets identified by LC-MS/MS with/without protease treatment are shown in bold black.^a^Theoritical molecular mass.^b^A Mascot score ≥30 is significant (*p* \< 0.05).^c^Sequence coverage is based on peptides with an unique sequence.

Functional classification of the identified proteins revealed that many of these proteins participate in a common molecular pathway (Table [4](#Tab4){ref-type="table"} and Figure [3](#Fig3){ref-type="fig"}C) and are involved in innate immunity, cell adhesion, cytoskeleton organization and virus replication.

Validation of cellular proteins incorporated into TAdV-3 virions {#Sec15}
----------------------------------------------------------------

Non availability of turkey host protein specific antisera made it difficult to verify the packaging of host proteins in TAdV-3 virions. However, human collagen alpha-1(VI) peptides showed 70% identity to turkey collagen alpha-1(VI) and chicken collagen alpha-1(VI) (Additional file [6](#MOESM6){ref-type="media"}). In addition, human haemoglobin peptides demonstrated 75% identity to turkey haemoglobin alpha and chicken haemoglobin alpha, 50% identity to turkey haemoglobin beta and 66% identity to chicken haemoglobin beta proteins (Additional file [7](#MOESM7){ref-type="media"}). Therefore, we attempted to determine the incorporation of collagen alpha-1(VI) and haemoglobin in purified TAdV-3 using Western blot assays. As shown in Figure [4](#Fig4){ref-type="fig"}, anti-collagen alpha-1 (VI) serum detected collagen alpha-1 (VI) chain specific band in proteinase K untreated TAdV-3 (panel A, lane 1). Similar protein could be detected in proteinase K treated purified TAdV-3 (panel A, lane 2). Anti-haemoglobin serum detected haemoglobin specific band in proteinase K untreated TAdV-3 (panel B, lane 1). Similar protein band could be detected in proteinase K treated purified TAdV-3 (panel B, lane 2).Figure 4**Western blot analysis of host proteins in TAdV-3.** Proteins from the proteinase K untreated purified TAdV-3 virions (panels **A**, **B**, lane 1) and proteinase K (20 μg incubated in 1 mL of MNT buffer) treated purified TAdV-3 virions (panels **A**, **B**, lane 2) were separated by 10--15% SDS-PAGE, transferred to nitrocellulose and analyzed by Western blot using anti-collagen alpha-1(VI) chain serum (panel **A**) and anti-haemoglobin serum (panel **B**). Molecular weight markers (Lane M).

Discussion {#Sec16}
==========

Viruses exploit multiple host proteins for successful entry, establishment of infection, replication, and immune evasion. For a better understanding of the TAdV-3-host interactions, we performed a comprehensive analysis of the protein content of TAdV-3 virions, using a LC-MS/MS based proteomic approach. To the best of our knowledge, incorporation of host proteins in adenovirus has not been reported so far.

The proteomic analysis of CsCl~2~ purified TAdV-3 identified a total of 13 virion proteins and 18 host proteins. Earlier, proteomic analysis has not reported the detection of host proteins in purified HAdV-5 virions \[[@CR15],[@CR16]\]. It is possible that the observed host proteins identified by proteomic analysis of CsCl~2~ purified TAdV-3 virions may not be actually incorporated in the purified virions but are loosely associated on the outside of the TAdV-3 virion capsids. Since proteinase K treatment has been traditionally used to remove any contaminating protein from the surface of enveloped viruses \[[@CR33],[@CR35]\], we used protease treatment of non-enveloped TAdV-3 to remove the potential contaminating proteins. Several lines of evidence validate the approach and suggest that proteinase K treatment of TAdV-3 appears successful in removing contamination proteins. 1) Intact virions could be detected by TEM after proteinase K treatment of TAdV-3. 2) Western blot analysis of protease K treated TAdV-3 detected hexon protein but not fiber protein (protruding from the capsid). 3) The fiber and 22 K (non structural protein) could not be detected by MS analysis of proteinase K treated TAdV-3. 4) Only 18 of the 26 host proteins could be identified in proteinase K treated TAdV-3.

Interestingly, all major viral proteins were identified in proteinase K treated virions (Table [3](#Tab3){ref-type="table"}) except viral pTP, possibly due to its low abundance and least mascot score values observed (Table [1](#Tab1){ref-type="table"}). Overall sequence coverage observed for different viral peptides ranged from 2 to 70%, with the majority between 10 and 35%.

Earlier, sequence analysis of turkey adenovirus-3 identified a hypothetical protein ORF 4 (named TaVgp04) \[[@CR7]\], which appears to be conserved in raptor adenovirus-1 \[[@CR36]\] and South polar skua adenovirus \[[@CR37]\]. In contrast, a hypothetical hydrophobic protein was identified in frog adenovirus 1 \[[@CR8]\], which shows no similarity to similar proteins identified in turkey adenovirus 3 \[[@CR7]\] and raptor adenovirus 1 \[[@CR36]\]. Our results suggest that an ORF4 of TAdV-3 encodes a structural protein TaVgp04, which is incorporated into virion capsid (Additional file [1](#MOESM1){ref-type="media"}). In addition, this is the first report to suggest the existence of TaVgp04 as a structural protein in siadenoviruses particularly of avian origin.

The proteomic analysis of proteinase K treated purified virions identified eleven cellular proteins incorporated in TAdV-3, which have been identified in other viruses (Table [4](#Tab4){ref-type="table"}). In addition, proteomic analysis identified seven host proteins incorporated in TAdV-3 virions (Table [4](#Tab4){ref-type="table"}), which have not been identified so far in any other virus. Interestingly, of the 18 detected host proteins, five of the proteins were only detected in proteinase K treated TAdV-3. It is possible that high abundance non-specific proteins might have masked the detection of these proteins in virions not treated with proteinase K that are truly virion associated, but present in low copy numbers.

Though earlier reports have demonstrated the packaging of viral \[[@CR38]\] or non viral RNAs \[[@CR39]\] into purified adenovirus, recent reports have not described the detection of any cellular protein in purified Lizard adenovirus-2 \[[@CR40]\], a member of *Atadenovirus* genus and purified HAdV-5, a prototype of *Mastadenoviru*s genus \[[@CR15]\]. The absence of a cellular protein packaged in purified adenovirus virions could be due to variety of reasons. As stated, the difference could be due to the technique used for analysis \[[@CR15]\]. Alternatively, it is possible that packaging of the cellular proteins may be dependent on the type of adenovirus (TAdV-3, a prototype of *Siadenovirus* genus) and origin of cells used for virus cultivation \[[@CR15]\].

The host proteins packaged inTAdV-3 are known to play important roles in enhancing the cell-to-cell spread of virus, transcription and virus replication (Table [4](#Tab4){ref-type="table"}, Figure [3](#Fig3){ref-type="fig"}). For example, extracellular matrix (collagen) has been shown to increase infectious Sindbis virus titers from BHK cells by enhancing post-infection cell survival \[[@CR41]\]. In another study, rotavirus-induced PI3K activation resulted in prolonged adherence of infected cells to collagen and increased virus production \[[@CR42]\]. Similarly, extracellular matrix vitronectin has been reported to enhance the growth of human adenovirus19 (HAdV-19) \[[@CR43]\].

However, the incorporation of antiviral host defense factors including, protein PML, haemoglobin and antimicrobial peptide (THP-2) into TAdV-3 virions is particularly intriguing. All of these host defence factors have been implicated in establishing antiviral environments. Recent studies have implicated PML in maintaining host antiviral defence and revealed different strategies developed by viruses to disrupt PML nuclear bodies \[[@CR44]-[@CR46]\]. In addition, protein PML has been shown to be important for the inhibition of adenovirus replication \[[@CR47]\]. Similarly, avian antimicrobial peptide THP-2, a member of beta-defensin family is effector of the innate defence system and play key functions during host defence by generating vigorous cytokine response \[[@CR48],[@CR49]\]. On the other hand, a novel role of haemoglobin in innate immunity has been recently reported for classical swine fever virus (CSFV) \[[@CR50]\] as silencing of haemoglobin expression using siRNA promoted CSFV growth and replication, whereas overexpression of haemoglobin antagonized CSFV replication and growth by triggering IFN signalling \[[@CR50]\].

Although TAdV-3 grows efficiently in spleen of infected turkey, virus grows poorly in primary or established cell lines. It is tempting to speculate that integration of certain established antiviral host restriction factors into viral particles may play a role in determining TAdV-3 replication "in vitro". Additional studies need to be performed in order to investigate whether these proteins are functionally required for virus entry, replication and pathogenesis. Future availability of reagents and a reliable cell culture system to grow TAdV-3 should make it possible to determine the role of individual host restriction factor in TAdV-3 replication.

Additional files {#Sec17}
================

Additional file 1:**Novel viral protein TaV3gp04.** Sequence showing peptides detected in LC-MS/MS.Additional file 2:**Amino acid sequence of protein PML.** Sequence showing peptides detected in LC-MS/MS.Additional file 3:**Amino acid sequence of collagen alpha-1(VI) chain.** Sequence showing peptides detected in LC-MS/MS.Additional file 4:**Amino acid sequence of haemoglobin subunit alpha-A-like.** Sequence showing peptides detected in LC-MS/MS.Additional file 5:**Amino acid sequence of haemoglobin subunit beta-like.** Sequence showing peptides detected in LC-MS/MS.Additional file 6:**Amino acid sequence similarity of collagen alpha-1(VI) peptides.** i) Human (accession number NP_001839) ii) turkey (accession number XP_003207392.1) iii) chicken (accession number CAA45788.1) peptide residues. Numbers to the left are the peptide position in coding sequence of the protein. Matched peptides shown in color.Additional file 7:**Amino acid sequence similarity of Haemoglobin peptides.** i) Human haemoglobin (accession number NP_000549.1) ii) Chicken haemoglobin alpha (accession number NP_001004376.1) iii) Chicken haemoglobin beta (NP_990820.1) iv) Turkey haemoglobin alpha (accession number XP_003210796.1) V) Turkey haemoglobin beta (accession number XP_003203315.1) peptide residues. Numbers to the left are the peptide position in coding sequence. Matched peptides shown in colour.
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